JPRN-UMIN000008397招募中1 期
Clinical trial of WT1 peptide therapy after WT1 and/or tumor lysates-pulsed dendritic cell vaccination therapy for patients with malignant glioma - Clinical trial of WT1 peptide therapy after WT1 and/or tumor lysates-pulsed dendritic cell vaccination therapy for patients with malignant glioma
Group of WT1 peptide therapy in Shinshu Universiry Hospital0 个研究点目标入组 12 人开始时间: 2012年8月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) The patient had received the WT1 peptide therapy previously.
研究者
相似试验
招募中
1 期
Phase 1 study of WT1 peptide vaccine therapy for high risk leukemia patients after hematopoietic stem cell transplantatioAcute myeloid leukemia, Acute lymphoblastic leukemia, Chronic myeloid leukemia blastic phase, Myelodysplastic syndrome with high risk of relapse and/or excess blastsJPRN-UMIN000002089ational Cancer Research Center Hospital18
已完成
1 期
A pilot trial of immunotherapy with WT1 peptide vaccine for pediatric patients with bone or soft tissue sarcoma following conventional chemotherapy.Osteosarcoma Soft tissue sarcoma neuroblastoma Pediatric bone, soft tissue sarcoma at high risk of recurrence.JPRN-UMIN000005312Osaka Universty22
已完成
不适用
Phase I/II clinical study of WT1 peptide-based immunotherapy combined with Imatinib for chronic myelogeneous leukemiaJPRN-UMIN000003508Department of Cancer immunotherapy, Osaka University Graduate School of Medicine30
招募中
1 期
W10TR-GBM2JPRN-jRCTs061180085eba Tetsuya90
已完成
1 期
Phase I/II clinical trial of WT1 peptide vaccine therapy for lung, breast, pancreas, stomach, and colorectal cancerung, breast, pancreas, stomach, and colorectal cancerJPRN-UMIN000011029Shinshu University50